Search Results (3)

The new generation of food packaging should not only be biodegradable, but also provide additional protective properties for packaged products, extending their shelf life. In this paper, we present the results of research on cast-extruded poly(butylene succinate) (PBS) films coated with hydroxypropyl methylcellulose (HPMC) modified with CO₂ extract from sea buckthorn (ES) or its ethosomes (ET) at amounts of 1 or 5 pph per HPMC. In addition, the developed films were exposed to accelerated aging (UV radiation and elevated temperature) to determine its effect on the films’ properties. Based on SEM, it can be concluded that accelerated aging results in the uncovering of the extract and ethosomes from the coating’s bulk. GPC showed a decrease in the molecular weight of PBS after treatment, additionally amplified by the presence of HPMC. However, the addition of ES or ET in low concentrations reduced the level of polyester degradation. The presence of the modified coating and its treatment increased the oxygen barrier (a decrease from 324 cm³/m² × 24 h for neat PBS to 208 cm³/m² × 24 h for the coated and modified PBS ET5). Despite the presence of colored extract or ethosomes in the coating, the color differences compared with neat PBS were imperceptible (ΔE < 1). The addition of 5 pph of sea buckthorn extract or its ethosomes in combination with accelerated aging resulted in the complete inhibition of the growth of E. coli and S. aureus, which was not observed in non-aged samples. The results obtained demonstrate an improvement in bioactive properties and protection against the negative effects of UV radiation on the film due to the presence of ET or ES in the coating. The developed systems could be used in the food industry as active packaging. Full article

Diesel particulate matter is one of the most dangerous environmental stressors affecting human health. Many plant-derived compounds with antioxidant and anti-inflammatory properties have been proposed to protect the skin from pollution damage. Curcumin (CUR) has a plethora of pharmacological activities, including anticancer, antimicrobial, anti-inflammatory and antioxidant. However, it has low bioavailability due to its difficult absorption and rapid metabolism and elimination. CUR encapsulation in nanotechnological systems and its combination with biopotentiators such as piperine (PIP) can improve its pharmacokinetics, stability and activity. In this study, ethosomes (ETs) were investigated for CUR and PIP delivery to protect the skin from damage induced by diesel particulate matter. ETs were produced by different strategies and characterized for their size distribution by photon correlation spectroscopy, for their morphology by transmission electron microscopy, and for their drug encapsulation efficiency by high-performance liquid chromatography. Franz cells enabled us to evaluate in vitro the drug diffusion from ETs. The results highlighted that ETs can promote the skin permeation of curcumin. The studies carried out on their antioxidant activity demonstrated an increase in the antioxidant power of CUR using a combination of CUR and PIP separately loaded in ETs, suggesting their possible application for the prevention of skin damage due to exogenous stressors. Ex vivo studies on human skin explants have shown the suitability of drug-loaded ETs to prevent the structural damage to the skin induced by diesel engine exhaust exposure. Full article

This study reports two therapeutic peptides, insulin (INS, as a hydrophilic model peptide) and cyclosporine A (CysA, as a hydrophobic one), that can be administrated through a transdermal or dermal route by using spicule-based topical delivery systems in vitro and in vivo. We obtained a series of spicules with different shapes and sizes from five kinds of marine sponges and found a good correlation between the skin permeability enhancement induced by these spicules and their aspect ratio L/D. In the case of INS, Sponge Haliclona sp. spicules (SHS) dramatically increased the transdermal flux of INS (457.0 ± 32.3 ng/cm²/h) compared to its passive penetration (5.0 ± 2.2 ng/cm²/h) in vitro. Further, SHS treatment slowly and gradually reduced blood glucose to 13.1 ± 6.3% of the initial level in 8 h, while subcutaneous injection resulted in a rapid blood glucose reduction to 15.9 ± 1.4% of the initial level in 4 h, followed by a rise back to 75.1 ± 24.0% of the initial level in 8 h. In the case of CysA, SHS in combination with ethosomes (SpEt) significantly (p < 0.05) increased the accumulation of CysA in viable epidermis compared to other groups. Further, SpEt reduced the epidermis thickness by 41.5 ± 9.4% in 7 days, which was significantly more effective than all other groups. Spicule-based topical delivery systems offer promising strategies for delivering therapeutic peptides via a transdermal or dermal route. Full article